STEPHEN LOMBARDI: Open Payments
NPI 1396447678 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$944 in 36 payments from 14 companies in 2025. Trend: 2023 $405 · 2024 $1,258 · 2025 $944
Food & beverage: $944
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $187 |
| Boston Scientific Corporation | 2 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $109 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $98 |
| E.R. Squibb & Sons, L.L.C. | 4 | $66 |
| ABIOMED | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Alnylam Pharmaceuticals Inc. | 3 | $53 |
| BridgeBio Pharma, Inc. | 3 | $45 |
| PFIZER INC. | 2 | $36 |
Products named: WATCHMAN FLX, LOKELMA, Kerendia, LifeVest, LEQVIO, ONPATTRO, FARXIGA, Attruby.
Industry payments across NC — which companies pay providers there.
